Keros Therapeutics (NASDAQ:KROS) reported quarterly losses of $(0.87) per share. This is a 45 percent decrease over losses of $(0.60) per share from the same period last year.
IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer’s Using THC
India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.”
